Cargando…

Effects of Mifepristone on Nonalcoholic Fatty Liver Disease in a Patient with a Cortisol-Secreting Adrenal Adenoma

Cushing syndrome (CS), a complex, multisystemic condition resulting from prolonged exposure to cortisol, is frequently associated with nonalcoholic fatty liver disease (NAFLD). In patients with adrenal adenoma(s) and NAFLD, it is essential to rule out coexisting endocrine disorders like CS, so that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ragucci, Enzo, Nguyen, Dat, Lamerson, Michele, Moraitis, Andreas G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733994/ https://www.ncbi.nlm.nih.gov/pubmed/29348947 http://dx.doi.org/10.1155/2017/6161348

Ejemplares similares

Evaluation of Evidence of Adrenal Insufficiency in Trials of Normocortisolemic Patients Treated With Mifepristone
por: Yuen, Kevin C. J., et al.
Publicado: (2017)

No Postoperative Adrenal Insufficiency in a Patient with Unilateral Cortisol-Secreting Adenomas Treated with Mifepristone Before Surgery
por: Saroka, Rachel M., et al.
Publicado: (2016)

SUN-460 Anticipating Hypokalemia in Patients With ACTH-Dependent Cushing Syndrome Treated With Mifepristone: Utilization of Cortisol and ACTH Levels to Identify At-Risk Patients
por: Moraitis, Andreas, et al.
Publicado: (2019)

MON-163 A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of a Selective Glucocorticoid Receptor Modulator, Relacorilant, in Patients with Autonomous Cortisol Secretion Due to Cortisol-Secreting Adrenal Adenoma(s)/Hyperplasia
por: Auchus, Richard Joseph, et al.
Publicado: (2020)

Mifepristone Treatment in Four Cases of Primary Bilateral Macronodular Adrenal Hyperplasia (BMAH)
por: Cohan, Pejman, et al.
Publicado: (2019)

Mifepristone Reduces Insulin Resistance in Patient Volunteers with Adrenal Incidentalomas That Secrete Low Levels of Cortisol: A Pilot Study
por: Debono, Miguel, et al.
Publicado: (2013)

Intracellular Molecular Differences in Aldosterone- Compared to Cortisol-Secreting Adrenal Cortical Adenomas
por: Seidel, Eric, et al.
Publicado: (2016)

SAT341 Even Mild Cortisol Excess Is Unsafe: Use of Mifepristone In Mild Autonomous Cortisol Secretion
por: Cruz, Alegyari Figueroa, et al.
Publicado: (2023)

Biochemical and Radiological Changes in Liver Steatosis Following Mifepristone Treatment in Patients With Hypercortisolism
por: Parker, John C., et al.
Publicado: (2021)

Cardiovascular Outcomes in Autonomous Cortisol Secretion and Nonfunctioning Adrenal Adenoma: A Systematic Review
por: Park, Jane, et al.
Publicado: (2019)

SUN-372 A Case of Adrenal Adenoma Co-Secreting Aldosterone and Cortisol: Limits of Adrenal Vein Sampling
por: Reddy, Ramadurgam Poliki Monica, et al.
Publicado: (2019)

Nonalcoholic fatty liver disease with prolactin-secreting pituitary adenoma in an adolescent: A case report
por: Takaki, Yugo, et al.
Publicado: (2018)

Mifepristone Improves Octreotide Efficacy in Resistant Ectopic Cushing's Syndrome
por: Moraitis, Andreas G., et al.
Publicado: (2016)

ODP322 Impact of Mifepristone on Liver Function and Resolution of Liver Steatosis in Patients with Cushing Syndrome – A Case Study
por: East, Honey E, et al.
Publicado: (2022)

Adrenal Incidentalomas and Other Endocrine-Related Adenomas: How Much Does Cortisol Secretion Matter?
por: Herrera-Martínez, Aura D., et al.
Publicado: (2023)

A Cortisol-Secreting Adrenal Adenoma Combined With a Micro-Pheochromocytoma: Case Report and Literature Review
por: Sakai, Kimiko, et al.
Publicado: (2023)

ACTH-independent Cushing’s syndrome with bilateral cortisol-secreting adrenal adenomas: a case report and review of literatures
por: Wei, Jia, et al.
Publicado: (2018)

FRI181 Increased LDL Particle And Apolipoprotein B Concentrations In Patients With Nonfunctioning And Cortisol Secreting Adrenal Adenomas
por: Sandooja, Rashi, et al.
Publicado: (2023)

The Value of Adrenal Androgens for Correcting Cortisol Lateralization in Adrenal Venous Sampling in Patients with Normal Cortisol Secretion
por: Zhang, Wenjing, et al.
Publicado: (2019)

The Risk of Colorectal Adenoma in Nonalcoholic or Metabolic-Associated Fatty Liver Disease
por: Seo, Ji-Yeon, et al.
Publicado: (2021)

Clinical Characteristics of Aldosterone- and Cortisol-Coproducing Adrenal Adenoma in Primary Aldosteronism
por: Tang, Lu, et al.
Publicado: (2018)

Aberrant DNA methylation of synaptophysin is involved in adrenal cortisol-producing adenoma
por: Zhong, Jia-Yu, et al.
Publicado: (2019)

Aldosterone- and cortisol-cosecreting adrenal adenoma, ovarian hyperthecosis and breast cancer
por: J Orrego, John, et al.
Publicado: (2020)

Analysis of clinical and pathological features of primary bilateral macronodular adrenocortical hyperplasia compared with unilateral cortisol-secreting adrenal adenoma
por: Zhang, Qian, et al.
Publicado: (2020)

FRI185 Post-adrenalectomy Improvement Of Kidney Function In Patients With Mild Autonomous Cortisol Secretion And Nonfunctioning Adrenal Adenoma
por: Rahimi, Leili, et al.
Publicado: (2023)

Investigating the role of cortisol and growth hormone in fatty liver development: fatty liver index in patients with pituitary adenomas
por: Auer, Matthias K., et al.
Publicado: (2016)

Liver fibrosis is associated with risk for colorectal adenoma in patients with nonalcoholic fatty liver disease
por: Kim, Min Cheol, et al.
Publicado: (2019)

Characterization of Cortisol Secretion Rate in Secondary Adrenal Insufficiency
por: Dorin, Richard I., et al.
Publicado: (2017)

Diagnostic testing of autonomous cortisol secretion in adrenal incidentalomas
por: Ueland, Grethe Å, et al.
Publicado: (2020)

Adrenal Hemorrhage in a Cortisol-Secreting Adenoma Caused by Antiphospholipid Syndrome Revealed by Clinical and Pathological Investigations: A Case Report
por: Ochi, Kentaro, et al.
Publicado: (2022)

Hypertension with unilateral adrenal aldosterone and cortisol cosecreting adenoma: A case report
por: Hu, Zhe, et al.
Publicado: (2021)

Effects of Ketoconazole on the Pharmacokinetics of Mifepristone, a Competitive Glucocorticoid Receptor Antagonist, in Healthy Men
por: Nguyen, Dat, et al.
Publicado: (2017)

Mifepristone Accelerates HPA Axis Recovery in Secondary Adrenal Insufficiency
por: Cohan, Pejman
Publicado: (2016)

Androgen Secreting Adenoma Co- Secreting Cortisol First Diagnosed During Pregnancy
por: Al Ghareeb, Zahra, et al.
Publicado: (2021)

The relevance of cortisol co-secretion from aldosterone-producing adenomas
por: Bhatt, Padmanabh S., et al.
Publicado: (2019)

Benign adrenal adenomas secreting excess mineralocorticoids and glucocorticoids
por: Yoon, Vivienne, et al.
Publicado: (2013)

PSAT030 A Clinically Dormant Adrenal Incidentaloma Evolving to A Cortisol Secreting Adenoma, A Ten Year Follow Up Experience
por: Batra, Saumya, et al.
Publicado: (2022)

Aldosterone- and cortisol-co-producing adrenal adenoma without clinical features of Cushing syndrome
por: Chang, Kyung Yoon, et al.
Publicado: (2014)

Decreased Sclerostin Secretion in Humans and Mice With Nonalcoholic Fatty Liver Disease
por: Zhou, Fangli, et al.
Publicado: (2021)

Adrenocorticotropic Hormone-Independent Cushing Syndrome with Bilateral Cortisol-Secreting Adenomas
por: Ku, Eu Jeong, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_k51v5vp3mabm7cgu37ag0bc4l4